Robert J Coffey Selected Research

Stomach Neoplasms (Stomach Cancer)

1/2022	A CGA/EGFR/GATA2 positive feedback circuit confers chemoresistance in gastric cancer.
12/2018	Expression of LRIG1, a Negative Regulator of EGFR, Is Dynamically Altered during Different Stages of Gastric Carcinogenesis.
1/2013	Helicobacter pylori promotes the expression of Krüppel-like factor 5, a mediator of carcinogenesis, in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert J Coffey Research Topics

Disease

60	Neoplasms (Cancer) 01/2024 - 02/2002
47	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 02/2002
12	Carcinogenesis 01/2024 - 02/2002
9	Adenoma (Adenomas) 12/2023 - 02/2002
8	Neoplasm Metastasis (Metastasis) 12/2022 - 11/2003
8	Colonic Neoplasms (Colon Cancer) 02/2022 - 03/2004
7	Inflammation (Inflammations) 01/2023 - 04/2007
7	Metaplasia 01/2019 - 04/2003
6	Carcinoma (Carcinomatosis) 01/2018 - 02/2002
4	Chronic Pain 07/2014 - 12/2002
4	Pain (Aches) 09/2013 - 12/2002
3	Polyps 12/2023 - 11/2006
3	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2013
3	Infections 01/2021 - 06/2004
3	Nausea 09/2013 - 07/2005
3	Atrophy 12/2012 - 05/2005
2	Disease Progression 12/2022 - 06/2010
2	Cysts 01/2021 - 01/2017
2	Necrosis 10/2020 - 03/2004
2	Rectal Neoplasms (Rectal Cancer) 07/2015 - 11/2006
2	Adenocarcinoma 01/2015 - 12/2005
2	Edema (Dropsy) 09/2013 - 07/2005
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2012 - 06/2010
2	Vomiting 12/2010 - 07/2005
2	Polycystic Kidney Diseases (Polycystic Kidney Disease) 06/2010 - 02/2004
2	Hemorrhage 06/2010 - 07/2005
2	Autosomal Recessive Polycystic Kidney (Polycystic Kidney Disease, Infantile, Type I) 03/2008 - 02/2004
2	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2005 - 06/2005
1	Glioblastoma (Glioblastoma Multiforme) 10/2023
1	Mood Disorders (Mood Disorder) 01/2022

Drug/Important Bio-Agent (IBA)

26	Proteins (Proteins, Gene)FDA Link 09/2023 - 11/2003
14	Cetuximab (Erbitux)FDA Link 01/2024 - 07/2005
12	ErbB Receptors (EGF Receptor)IBA 09/2023 - 02/2002
9	LigandsIBA 01/2024 - 03/2002
9	Biomarkers (Surrogate Marker)IBA 12/2018 - 11/2006
7	Cadherins (E-Cadherin)IBA 12/2017 - 11/2003
7	Transforming Growth Factor alpha (TGF-alpha)IBA 02/2008 - 07/2004
6	AmphiregulinIBA 04/2015 - 06/2005
5	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2023 - 04/2003
4	MicroRNAs (MicroRNA)IBA 01/2024 - 10/2018
4	Leucine (L-Leucine)FDA Link 09/2023 - 07/2014
4	Calcibiotic Root Canal SealerIBA 12/2021 - 11/2006
4	Epidermal Growth Factor (EGF)IBA 01/2021 - 04/2003
4	spasmolytic polypeptideIBA 01/2019 - 05/2007
4	ProteomeIBA 10/2018 - 03/2004
4	Opioid Analgesics (Opioids)IBA 07/2010 - 12/2002
4	ProstaglandinsIBA 11/2006 - 09/2002
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 09/2023 - 04/2004
3	Celecoxib (Celebrex)FDA Link 01/2023 - 11/2006
3	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2023 - 01/2018
3	EnzymesIBA 01/2023 - 11/2006
3	Dextrans (Dextran)FDA Link 01/2023 - 01/2018
3	Monoclonal AntibodiesIBA 12/2022 - 05/2017
3	Messenger RNA (mRNA)IBA 12/2022 - 01/2013
3	Glutamine (L-Glutamine)FDA Link 01/2022 - 01/2018
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 04/2003
3	IntegrinsIBA 01/2021 - 02/2013
3	CateninsIBA 12/2017 - 01/2011
3	Delta CateninIBA 12/2017 - 01/2011
3	Tamoxifen FDA LinkGeneric 07/2014 - 01/2011
3	beta CateninIBA 12/2009 - 01/2007
2	tyrosine receptor (receptor, tyrosine)IBA 01/2024 - 01/2007
2	Phosphotransferases (Kinase)IBA 01/2024 - 01/2007
2	Phenobarbital (Luminal)FDA Link 12/2023 - 06/2010
2	Small Cytoplasmic RNAIBA 12/2023 - 01/2022
2	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 09/2023 - 05/2014
2	AzoxymethaneIBA 01/2023 - 01/2022
2	CytokinesIBA 12/2020 - 07/2004
2	Oncogene Proteins (Oncogene Protein)IBA 01/2019 - 03/2004
2	Circular RNAIBA 10/2018 - 11/2016
2	Collagen Type I (Type I Collagen)IBA 05/2017 - 01/2017
2	AntibodiesIBA 01/2016 - 03/2004
2	Caspase 3 (Caspase-3)IBA 04/2014 - 11/2008
2	ThymidineIBA 01/2014 - 01/2013
2	AgarIBA 10/2013 - 08/2004
2	DMP 777IBA 12/2012 - 05/2007
2	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 05/2011 - 04/2003
2	AntigensIBA 06/2010 - 01/2007
2	Heparin (Liquaemin)FDA LinkGeneric 07/2005 - 04/2003
2	MetallothioneinIBA 05/2005 - 07/2004
1	Small Nuclear RNA (snRNA)IBA 01/2024
1	Fluorouracil (Carac)FDA LinkGeneric 01/2024
1	Small Nucleolar RNA (snoRNA)IBA 01/2024
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2024
1	Peptide Hydrolases (Proteases)FDA Link 01/2024
1	AnionsIBA 10/2023
1	LDN 193189IBA 09/2023
1	CarcinogensIBA 09/2023
1	GPI-Linked ProteinsIBA 06/2023
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2023
1	fluorocoxib AIBA 01/2023
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2023
1	Poloxamer (Poloxamer 407)IBA 01/2023
1	Long Noncoding RNAIBA 12/2022
1	Calcium-Binding ProteinsIBA 02/2022

Therapy/Procedure

15	Therapeutics 01/2024 - 06/2002
5	Drug Therapy (Chemotherapy) 01/2024 - 12/2011
3	Precision Medicine 01/2020 - 04/2014
3	Infusion Pumps (Infusion Pump) 07/2014 - 02/2007
3	Lasers (Laser) 03/2013 - 07/2007